Anika Reports Second Quarter 2025 Financial Results
(NASDAQ:ANIK), Regenerative Solutions revenue up 41% with Integrity(TM) Implant System ahead of expectations and continued strong Hyalofast(R) growth; Integrity surpasses full year 2024 performance and is on pace to more than double in 2025 Company released topline results for Hyalofast(R) clinical trial which did not meet pre-specified co-primary end points; Hyalofast demonstrated statistically significant improvements […]